DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)
Q4 2023 13F-HR Holdings
Net value change ($000)
+876,846
(19.3%)
New positions
154
Sold out positions
14
Turnover %
11.1%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q3 2023
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| NUVL | 552,152 | 60.1% |
| OSCR | 102,908 | NEW |
| SpringWorks Therapeutics, Inc. | 57,810 | 158.3% |
| Fusion Pharmaceuticals Inc. | 54,174 | 738.1% |
| CPRX | 53,658 | 56.0% |
| BAX | 52,527 | NEW |
| RVMD | 40,142 | 82.8% |
| RayzeBio, Inc. | 36,818 | 143.1% |
| KURA | 36,506 | 91.5% |
| BKD | 33,603 | 64.0% |
Top Reduces (Value $000, Stocks/ETFs)
| INTERCEPT PHARMACEUTICALS, INC. | -38,524 | -100.0% |
| CareMax, Inc. | -25,743 | -76.5% |
| AHCO | -24,630 | -19.9% |
| ROIV | -18,740 | -100.0% |
| GH | -18,003 | -45.7% |
| NBIX | -17,941 | -13.2% |
| CRBU | -16,730 | -100.0% |
| BIO | -13,409 | -21.5% |
| TARS | -13,399 | -100.0% |
| DNLI | -12,275 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|